Neuren Pharmaceuticals Statistics

Total Valuation

ASX:NEU has a market cap or net worth of AUD 1.38 billion. The enterprise value is 1.16 billion.

Market Cap	1.38B
Enterprise Value	1.16B

Important Dates

The next estimated earnings date is Friday, May 30, 2025.

Earnings Date	May 30, 2025
Ex-Dividend Date	n/a

Share Statistics

ASX:NEU has 125.43 million shares outstanding. The number of shares has increased by 0.01% in one year.

Current Share Class	n/a
Shares Outstanding	125.43M
Shares Change (YoY)	+0.01%
Shares Change (QoQ)	-0.06%
Owned by Insiders (%)	3.07%
Owned by Institutions (%)	16.22%
Float	109.16M

Valuation Ratios

The trailing PE ratio is 10.14 and the forward PE ratio is 63.07.

PE Ratio	10.14
Forward PE	63.07
PS Ratio	6.37
PB Ratio	3.79
P/TBV Ratio	3.79
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.47, with an EV/FCF ratio of -102.72.

EV / Earnings	8.16
EV / Sales	5.34
EV / EBITDA	6.47
EV / EBIT	6.47
EV / FCF	-102.72

Financial Position

The company has a current ratio of 8.73

Current Ratio	8.73
Quick Ratio	8.69
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 49.92% and return on invested capital (ROIC) is 39.35%.

Return on Equity (ROE)	49.92%
Return on Assets (ROA)	34.05%
Return on Invested Capital (ROIC)	39.35%
Return on Capital Employed (ROCE)	49.23%
Revenue Per Employee	27.10M
Profits Per Employee	17.76M
Employee Count	8
Asset Turnover	0.66
Inventory Turnover	n/a

Taxes

In the past 12 months, ASX:NEU has paid 48.04 million in taxes.

Income Tax	48.04M
Effective Tax Rate	23.42%

Stock Price Statistics

The stock price has decreased by -42.89% in the last 52 weeks. The beta is 1.85, so ASX:NEU's price volatility has been higher than the market average.

Beta (5Y)	1.85
52-Week Price Change	-42.89%
50-Day Moving Average	11.83
200-Day Moving Average	13.86
Relative Strength Index (RSI)	50.77
Average Volume (20 Days)	1,216,699

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:NEU had revenue of AUD 216.83 million and earned 142.04 million in profits. Earnings per share was 1.09.

Revenue	216.83M
Gross Profit	183.86M
Operating Income	179.16M
Pretax Income	182.94M
Net Income	142.04M
EBITDA	179.18M
EBIT	179.16M
Earnings Per Share (EPS)	1.09

Full Income Statement

Balance Sheet

The company has 222.24 million in cash and n/a in debt, giving a net cash position of 222.24 million or 1.77 per share.

Cash & Cash Equivalents	222.24M
Total Debt	n/a
Net Cash	222.24M
Net Cash Per Share	1.77
Equity (Book Value)	363.90M
Book Value Per Share	2.87
Working Capital	353.57M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -11.27 million and capital expenditures -10,000, giving a free cash flow of -11.28 million.

Operating Cash Flow	-11.27M
Capital Expenditures	-10,000
Free Cash Flow	-11.28M
FCF Per Share	-0.09

Full Cash Flow Statement

Margins

Gross margin is 84.79%, with operating and profit margins of 82.63% and 65.51%.

Gross Margin	84.79%
Operating Margin	82.63%
Pretax Margin	84.37%
Profit Margin	65.51%
EBITDA Margin	82.64%
EBIT Margin	82.63%
FCF Margin	n/a

Dividends & Yields

ASX:NEU does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.01%
Shareholder Yield	-0.01%
Earnings Yield	10.29%
FCF Yield	-0.82%

Stock Splits

The last stock split was on November 21, 2017. It was a reverse split with a ratio of 0.05.

Last Split Date	Nov 21, 2017
Split Type	Reverse
Split Ratio	0.05

Scores

ASX:NEU has an Altman Z-Score of 33.7 and a Piotroski F-Score of 6.

Altman Z-Score	33.7
Piotroski F-Score	6